SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001144204-19-029816
Filing Date
2019-06-05
Accepted
2019-06-05 08:06:01
Documents
7
Effectiveness Date
2019-06-05

Document Format Files

Seq Description Document Type Size
1 DEFA14A tv523005_defa14a.htm DEFA14A 27359
2 GRAPHIC image_001.jpg GRAPHIC 393297
3 GRAPHIC image_002.jpg GRAPHIC 200997
4 GRAPHIC image_003.jpg GRAPHIC 68223
5 GRAPHIC image_004.jpg GRAPHIC 94822
6 GRAPHIC image_005.jpg GRAPHIC 40621
7 GRAPHIC image_006.jpg GRAPHIC 35231
  Complete submission text file 0001144204-19-029816.txt   1172168
Mailing Address 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036 (973) 242-0005
Neurotrope, Inc. (Filer) CIK: 0001513856 (see all company filings)

IRS No.: 463522381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38045 | Film No.: 19878558
SIC: 2834 Pharmaceutical Preparations